Skip to content
OpenCapital
Get started

QuidelOrtho Corporation QDEL China — R&D

Other segment segments

Latin America
$500K+25.0%
EMEA
$400K-33.3%
North America
$400K0.0%
JPAC
$300K-25.0%

Similar metrics at other companies

MSA
MSAInternational — R&D
$6.72M+6.6%
Brady Corporation logo
BRCAmericas & Asia — R&D
$16.95M+27.3%
ESAB logo
ESABCapitalized R&D costs
$22.04M+7.2%
Curtiss-Wright logo
CWCapitalized R&D
$52.53M-13.6%
BillionToOne, Inc. logo
BLLNCapitalized R&D expenditure
$6.06M-47.2%
Haemonetics logo
HAEHospital — R&D
$8.46M-6.2%

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$832.61M-56.1%
Enterprise value$3.8B-22.0%
P/S0.3×-0.4×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%—

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept qdel:SegmentInformationResearchAndDevelopmentExpense.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's china — r&d.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's china — R&D?
QuidelOrtho Corporation (QDEL) reported china — R&D of $700K in Q1 2026.
How has QuidelOrtho Corporation's china — R&D changed year-over-year?
QuidelOrtho Corporation's china — R&D decreased by 22.2% year-over-year, from $900K to $700K.
What is the long-term trend for QuidelOrtho Corporation's china — R&D?
Over 3 years (2022 to 2025), QuidelOrtho Corporation's china — R&D has grown at a 8.9% compound annual growth rate (CAGR), from $2.4M to $3.1M.
What does china — R&D mean?
Reflects the capital and operational resources allocated to research and development activities specifically tailored for the China market. It indicates the company's commitment to local innovation and adapting diagnostic technologies to meet regional clinical requirements.